March 7, 2017 / 1:00 AM / 7 months ago

BRIEF-Creso signs binding LOI with Domaco

March 7 (Reuters) - Creso Pharma Ltd:

* Creso signs binding Letter Of Intent (LOI) with Domaco

* Creso secures binding LOI with high-tech Swiss food and pharma development company, Domaco, Dr med Aufdermaur AG

* LOI for development and commercialisation of new cannabinoid-rich nutraceutical products for human and animal health

* Agreement also includes development of new animal health nutraceutical product for companion animals Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below